Pasithea Therapeutics appointed Kartik Krishnan as chief medical officer effective May 1. The announcement is a routine management update with no financial terms, operational guidance, or clinical data disclosed. Market impact is likely minimal.
Pasithea Therapeutics appointed Kartik Krishnan as chief medical officer effective May 1. The announcement is a routine management update with no financial terms, operational guidance, or clinical data disclosed. Market impact is likely minimal.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
